Benign multicystic peritoneal mesothelioma

Acta Obstetricia et Gynecologica Scandinavica

Volumn 81, Issue 11, 2002, Pages 1083-1085

  M, H ^a   Oergensen, A J ^a   Rove, A G ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Benign cystic mesothelioma; Peritoneal cysts

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CYST; PERITONEUM MESOTHELIOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING;

ABDOMINAL PAIN; ADULT; DIAGNOSIS, DIFFERENTIAL; DOUGLAS' POUCH; FEMALE; HUMANS; MESOTHELIOMA; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS;

EID: 0036847906     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2002.811116.x     Document Type: Article

References (12)

1. Battifora H, McCaughey WTE. Atlas of tumor pathology. Tumors of the serosal membranes. AFIP 1995: 90-4.
2. Weiss SW, Tavassoli FA. Multicystic mesothelioma. An analysis of pathologic findings and biologic behavior in 37 cases. Am J Surg Pathol 1988; 12: 737-46.
3. Ross MJ, Welch WR, Scully RE. Multilocular peritoneal inclusion cysts (so-called cystic mesotheliomas). Cancer 1989; 64: 1336-46.
4. Cury PM, Butcher DN, Fisher C, Corrin B, Nicholson AG. Value of mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol 2000; 13: 107-12.
5. Doglioni C, Dis Tos AP, Laurino L, Iuzzolino P, Chiarelli C, Gelio M et al. Calretinin: A novel immunocytochemical marker for mesothelioma. Am J Surg Path 1996; 20: 1037-46.
6. Ordóñez NG. Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma. Am J Clin Pathol 1999; 112: 75-89.
7. Attanoos RL, Webb R, Dojcinov SD, Gibbs AR. Value of mesothelial and epithelial antibodies in distinguishing diffuse mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology 2002; 40: 237-44.
8. Brockstedt U, Gulyas M, Dobra K, Dejmek A, Hjerpe A. An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma. Am J Clin Pathol 2000; 114: 203-9.
9. Özgen A, Akata D, Akhan O, Tez M, Gedikoglu G, Özmen MN. Giant benign cystic peritoneal mesothelioma. US, CT MRI findings. Abdom Imaging 1998; 23: 502-4.
10. Letterie GS, Yon JL. Use of a long-acting GnRH agonist for benign cystic mesothelioma. Obstet Gynecol 1995; 85: 901-3.
11. Letterie GS, Yon JL. The antiestrogen tamoxifen in the treatment of recurrent benign cystic mesothelioma. Gynecol Oncol 1998; 70: 131-3.
12. Rosen DMB, Sutton CJG. Use of the potassium titanyl phosphate (KTP) laser in the treatment of benign multicystic peritoneal mesothelioma. Br J Obstet Gynaecol 1999; 106: 505-6.